US Patent Issued to Vertex Pharmaceuticals on March 18 for "Substituted quinoxalines and benzo[c[1,2,5oxadiazoles as DNA-PK inhibitors" (Massachusetts Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,251,387, issued on March 18, was assigned to Vertex Pharmaceuticals Inc. (Boston).

"Substituted quinoxalines and benzo[c[1,2,5oxadiazoles as DNA-PK inhibitors" was invented by John Patrick Maxwell (Hingham, Mass.), Paul S. Charifson (Framingham, Mass.), Qing Tang (Boston), Steven M. Ronkin (Watertown, Mass.), Katrina Lee Jackson (Cambridge, Mass.), Albert Charles Pierce (Cambridge, Mass.), David J. Lauffer (Stow, Mass.), Pan Li (Lexington, Mass.), Simon Giroux (Cambridge, Mass.), Jinwang Xu (Boston), Kevin Michael Cottrell (Cambridge, Mass.), Mark A. Morris (Somerville, Mass.), Nathan D. Waal (Cambridge, Mass.), John J. Court (Littleton, Mass.), Wenxin Gu (Concord, Mass.) and Hongbo ...